The number of death cases reached 1,980, with 39 new fatalities, while the number of patients in serious condition decreased from 838 to 824, out of 1,576 patients currently hospitalised, Xinhua news agency reported.
The number of recoveries rose to 228,658, with 2,933 new ones, while active cases currently stand at 59,854.
Earlier on Sunday, Tel Aviv University (TAU) in central Israel said it has been developing an antibody cocktail to treat and prevent Covid-19.
"The antibody cocktail, derived from the blood of Covid-19 patients in Israel, is a safe natural substance," TAU said.
The researchers said that since the antibodies are natural and remain stable in the blood, one injection can be protective from Covid-19 for several weeks, or even several months.
In their study, led by TAU and published in bioRxiv preprint platform, the researchers proved the effectiveness of the antibody cocktail in cell cultures, while the next stage will be a clinical trial in humans.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.